Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by JDavenporton Dec 12, 2022 11:49am
286 Views
Post# 35166227

Let me ponder this...

Let me ponder this...
Dr. Deborah Rathjen, secretly, without notice, without telling me, but telling others of it, apparently after listening to some shareholders who publicly blamed me, and attacked me, for influencing them to buy and hold stock for over ten years, cancelled my contract.
 
Froot Loops!
It sounds like the grocery store that kept running out of Froot Loops. 
Customer asks, "Where's my Froot Loops? How come I can't buy my Froot Loops anymore?"
"We stopped carrying them."
"What? Why not?"
"We kept running out of them and people were complaining. We can't carry a product that people complain about."
 
Sounds like DrDR, "We can't support a guy who influences people to buy the stock, and to hold the stock for ten years. People are blaming JD for that. We can't support a guy that people complain about." 
 
Here's a question.
Has anybody ever been angry at Colwell Capital or Stern IR for influencing them to buy too many Bioasis shares? And holding them? Don't laugh, but has anybody ever blamed DrDR for that?
 
Not hardly, pilgrim.
 
Well, at least Colwell is good at setting up roadshows, booking the rooms, ordering coffee, notifying the chosen few, convincing them that they're special, and then in these days of social media, managing to promote Bioasis in almost complete secrecy.
 
That's no small thing!

Secretly promoting a company!

Stern IR has been 100% effective for years at promoting Bioasis in complete and utter secrecy. The CIA costs billions a month. Stern does it for only $15,000.00 a month. 
 
My hat...!

I don't do secret too well.

jd
<< Previous
Bullboard Posts
Next >>